European Companies Search Engine
5 EU fundings (€527,319): Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 … BdlYear 2016 EU Research and Innovation programme "Horizon"
Text
Bolagsverket 5560117482
This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: AstraZeneca AB, Södertälje, Sweden.
The visualizations for "5 EU fundings (€527,319): Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 …"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.